Bone Growth Stimulators - Medical Devices Pipeline Assessment, 2016 - GlobalData

Bone Growth Stimulators - Medical Devices Pipeline Assessment, 2016

Bone Growth Stimulators - Medical Devices Pipeline Assessment, 2016 - GlobalData
Bone Growth Stimulators - Medical Devices Pipeline Assessment, 2016
Published Oct 07, 2016
70 pages — Published Oct 07, 2016
Price US$ 2,500.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

GlobalData's Medical Devices sector report, Bone Growth Stimulators - Medical Devices Pipeline Assessment, 2016' provides an overview of Bone Growth Stimulators currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Bone Growth Stimulators pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Bone Growth Stimulators under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Bone Growth Stimulators and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Bone Growth Stimulators under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the products current stage of development, territory and estimated launch date

  
Source:
Document ID
GDME0234EPD
Industry
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
1 Table of Contents24
  1.1 List of Tables41
  1.2 List of Figures51
2 Introduction61
  2.1 Bone Growth Stimulators Overview61
3 Products under Development75
  3.1 Bone Growth Stimulators - Pipeline Products by Stage of Development71
  3.2 Bone Growth Stimulators - Pipeline Products by Segment81
  3.3 Bone Growth Stimulators - Pipeline Products by Territory91
  3.4 Bone Growth Stimulators - Pipeline Products by Regulatory Path101
  3.5 Bone Growth Stimulators - Pipeline Products by Estimated Approval Date111
4 Bone Growth Stimulators - Pipeline Products under Development by Companies122
  4.1 Bone Growth Stimulators Companies - Pipeline Products by Stage of Development121
  4.2 Bone Growth Stimulators - Pipeline Products by Stage of Development131
5 Bone Growth Stimulators Companies and Product Overview1421
  5.1 Bionext Biotech Products Ltd. Company Overview141
    5.1.1 Bionext Biotech Products Ltd. Pipeline Products &Ongoing Clinical Trials Overview141
  5.2 Curative Biosciences, Inc. Company Overview151
    5.2.1 Curative Biosciences, Inc. Pipeline Products &Ongoing Clinical Trials Overview152
  5.3 Forticell Bioscience, Inc. Company Overview171
    5.3.1 Forticell Bioscience, Inc. Pipeline Products &Ongoing Clinical Trials Overview171
  5.4 GreenBone Ortho srl Company Overview181
    5.4.1 GreenBone Ortho srl Pipeline Products &Ongoing Clinical Trials Overview181
  5.5 Induce Biologics Inc. Company Overview191
    5.5.1 Induce Biologics Inc. Pipeline Products &Ongoing Clinical Trials Overview191
  5.6 KeraCure, Inc. (Inactive) Company Overview201
    5.6.1 KeraCure, Inc. (Inactive) Pipeline Products &Ongoing Clinical Trials Overview201
  5.7 Locate Therapeutics Limited Company Overview211
    5.7.1 Locate Therapeutics Limited Pipeline Products &Ongoing Clinical Trials Overview211
  5.8 Osiris Therapeutics, Inc. Company Overview221
    5.8.1 Osiris Therapeutics, Inc. Pipeline Products &Ongoing Clinical Trials Overview222
  5.9 OsteoGenix Incorporated (Inactive) Company Overview241
    5.9.1 OsteoGenix Incorporated (Inactive) Pipeline Products &Ongoing Clinical Trials Overview241
  5.10 REGENECURE, Ltd. Company Overview251
    5.10.1 REGENECURE, Ltd. Pipeline Products &Ongoing Clinical Trials Overview252
  5.11 Scil Technology GmbH (Inactive) Company Overview271
    5.11.1 Scil Technology GmbH (Inactive) Pipeline Products &Ongoing Clinical Trials Overview273
  5.12 Taxus Cardium Pharmaceuticals Group Inc. Company Overview301
    5.12.1 Taxus Cardium Pharmaceuticals Group Inc. Pipeline Products &Ongoing Clinical Trials Overview302
  5.13 Tornier, Inc. Company Overview321
    5.13.1 Tornier, Inc. Pipeline Products &Ongoing Clinical Trials Overview321
  5.14 Zimmer Biomet Holdings, Inc. Company Overview331
    5.14.1 Zimmer Biomet Holdings, Inc. Pipeline Products &Ongoing Clinical Trials Overview332
6 Bone Growth Stimulators- Recent Developments3532
  6.1 Sep 16, 2016: Osiris Provides Update Regarding NASDAQ Listing Status351
  6.2 Sep 15, 2016: Medtronic Names Mark Ploof Senior Vice President of Global Operations and Business Services351
  6.3 Sep 14, 2016: Nanovis to Raises USD3.8 Million in Venture Financing361
  6.4 Sep 13, 2016: Nanovis Raises USD1.1 Million in Venture Financing361
  6.5 Aug 25, 2016: Medtronic Reports First Quarter Financial Results363
  6.6 Aug 16, 2016: NovaBone Products Receives GMP Medical Device Certificate391
  6.7 Jul 28, 2016: Integer Holdings Reports 2016 Second Quarter Results393
  6.8 Jul 28, 2016: Zimmer Biomet Reports Second Quarter 2016 Financial Results421
  6.9 Jul 27, 2016: Anika Reports Second Quarter 2016 Financial Results421
  6.10 Jul 26, 2016: Globus Medical Reports Second Quarter 2016 Results431
  6.11 Jul 21, 2016: Stryker reports second quarter 2016 results441
  6.12 Jul 19, 2016: Bioventus Withdraws IPO451
  6.13 Jul 06, 2016: Bone Biologics Names Scott D. Boden, MD Chief Medical Advisor451
  6.14 Jun 30, 2016: NuVasive Agrees to Settle Patent Litigation With Medtronic461
  6.15 Jun 29, 2016: New chairman appointed at JRI Orthopaedics461
  6.16 Jun 27, 2016: Greatbatch Renamed Integer Holdings471
  6.17 Jun 24, 2016: Michael Minogue Named to Bioventus Board of Managers481
  6.18 Jun 13, 2016: Zimmer Biomet Raises USD1.28 Billion in Public Offering of Shares481
  6.19 Jun 07, 2016: Zimmer Biomet Plans to Raise USD750 Million in Public Offering of Notes481
  6.20 Jun 06, 2016: Medtronic Outlines Future Growth Vision at Investor Day491
  6.21 May 31, 2016: Medtronic Reports Fourth Quarter and Fiscal Year 2016 Financial Results493
  6.22 May 03, 2016: Globus Medical Reports First Quarter 2016 Results521
  6.23 Apr 28, 2016: Greatbatch Reports 2016 First Quarter Results522
  6.24 Feb 29, 2016: Greatbatch Reports 2015 Fourth Quarter and Full Year Results543
  6.25 Feb 25, 2016: Orthofix Study Shows Pulsed Electromagnetic Field Therapy May Reduce Cellular Inflammation Associated with Disc Degeneration571
  6.26 Feb 24, 2016: Globus Medical Reports Full Year and Fourth Quarter 2015 Results581
  6.27 Jan 19, 2016: Globus Medical Announces Litigation Settlement Agreement591
  6.28 Jan 12, 2016: Antibe Therapeutics Enters into Licensing Agreement with Induce Biologics591
  6.29 Jan 11, 2016: Bioventus Board of Managers Appoints Bill Hawkins Chairman591
  6.30 Jan 11, 2016: Greatbatch Provides Preliminary 2015 Revenue Results and 2016 Guidance601
  6.31 Jan 06, 2016: Globus Medical Reports Preliminary Fourth Quarter and Full Year Record Sales Results601
  6.32 Dec 03, 2015: Cytos Biotech Merges with Kuros Biosurgery611
  6.33 Dec 03, 2015: Cytos Biotechnology and Kuros Biosurgery to combine to create Kuros Biosciences611
  6.34 Nov 11, 2015: Kuros Biosurgery Raises Additional USD5 Million Financing621
  6.35 Nov 03, 2015: Globus Medical Reports Third Quarter 2015 Results621
  6.36 Oct 29, 2015: Greatbatch Reports 2015 Third Quarter Results633
  6.37 Oct 13, 2015: Greatbatch Raises USD360 Million in Private Placement of 9.125% Notes Due 2023661
7 Appendix674
  7.1 Methodology672
  7.2 About GlobalData691
  7.3 Contact Us691
  7.4 Disclaimer701

Table Of Contents

GlobalData—GlobalData uses proprietary data sources, tools and techniques to gather, analyze and represent the latest and the most reliable information essential for a business to sustain a competitive edge. GlobalData is a comprehensive source of insights and analysis with coverage across the oil & gas, power, alternative energy, nuclear power, petrochemicals, medical equipment and healthcare industries.

About the Author


Cite this Report

  
MLA:
GlobalData. "Bone Growth Stimulators - Medical Devices Pipeline Assessment, 2016" Oct 07, 2016. Alacra Store. May 12, 2025. <http://www.alacrastore.com/storecontent/GlobalData/Bone-Growth-Stimulators-Medical-Devices-Pipeline-Assessment-2016-2085-23762>
  
APA:
GlobalData. (2016). Bone Growth Stimulators - Medical Devices Pipeline Assessment, 2016 Oct 07, 2016. New York, NY: Alacra Store. Retrieved May 12, 2025 from <http://www.alacrastore.com/storecontent/GlobalData/Bone-Growth-Stimulators-Medical-Devices-Pipeline-Assessment-2016-2085-23762>
  
US$ 2,500.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Market Research from one place.